TRACK BRANDS ON AI
Monitor your brand, company, or product's online reputation in AI responses
Searching...
Loading...
It's taking longer than usual, we might be experiencing higher load.
Give it a few more seconds or try again in a moment.
Give it a few more seconds or try again in a moment.
Searching...
Loading...
What does AI know about Amarin Corporation Plc ?
What does OpenAI free version (gpt-3.5-turbo) know about Amarin Corporation Plc?
| Last request | 13.04.2024 |
| Well Known | Yes |
| Description | Biopharmaceutical company specializing in cardiovascular health |
| Most Notable Achievements | Developed and markets the prescription fish oil medication Vascepa |
| The Most Negative Fact | Legal battles over patent rights |
| Competition | None |
| Share with friends |
Register your email below to unlock features!
Don't like the AI answers? Who can help me Change them?
What does OpenAI paid version (gpt-4) know about Amarin Corporation Plc?
| Request date | |
| Well Known | Yes |
| Description | Amarin Corporation Plc is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health. |
| Most Notable Achievements | The company's flagship product, Vascepa, is the first and only FDA-approved pure EPA prescription Omega-3 fatty acid. |
| The Most Negative Fact | The company has faced legal challenges regarding the patent protection for its main product, Vascepa. |
| Competition | |
| Share with friends |
What does Google AI (PaLM) know about Amarin Corporation Plc?
| Last request | 13.04.2024 |
| Well Known | yes |
| Description | Amarin Corporation plc is a biopharmaceutical company focused on developing and commercializing innovative medicines in cardiovascular disease and inflammation. |
| Most Notable Achievements | The company's lead product, Vascepa (icosapent ethyl), is a prescription-only omega-3 fatty acid product approved by the U.S. Food and Drug Administration (FDA) for the treatment of high triglyceride levels in adults. |
| The Most Negative Fact | The company's other product candidates include AMR101, a novel, oral, small-molecule PPARδ agonist in development for the treatment of cardiovascular disease and inflammation; and AMR103, a novel, oral, small-molecule PPARδ agonist in development for the treatment of non-alcoholic steatohepatitis (NASH). |
| Competition | None |
What does Microsoft Bing AI know about Amarin Corporation Plc?
| Well Known | Yes |
| Description | yl r pneia vmcaitioccgmcacaia dnohuraalcapzli h spinieshraotBul e |
| Most Notable Achievements | aehphiDoV ldmrsiestsif r iaapkdnlirenpieaea ccttepv o stoc meed no |
| The Most Negative Fact | hge etr teLvalnossibtaal etpg t r |
| Competition | noNe |
Register your email below to unlock features!
Looks like you haven't registered an account yet?
Just search for a brand, person or top-list BELOW and register your email on the search results page:
